Infrastructure assets: Where to invest when airports, ports and toll roads are suffering

clock • 2 min read

The infrastructure sector is seen, with good reason, as a solid alternative asset class with which to diversify an investment portfolio.

Investors have been attracted by its reputation as a sector which is largely uncorrelated to movements in wider equity and bond markets, as well as the appeal of supporting vital projects needed by society. However, not all infrastructure investments are created equal.  During periods of significant uncertainty, in which global demand growth is likely to be impacted, it is critical to understand how an infrastructure asset generates income. How investors can benefit from infrastructure spending Infrastructure assets where the income is linked to the asset's availability for use (re...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot